Clinical Trials
12 trialsNCT05056077 2026-05-18
TTBF
University of California, San Francisco
Phase NA Active not recruiting
NCT06955910 2026-05-12
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Active not recruiting
NCT02400944 2026-04-07
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Memorial Sloan Kettering Cancer Center
Active not recruiting
NCT04964895 2025-12-17
QSCO
University Hospital, Toulouse
Completed
NCT05649306 2025-10-03
Gender Related Coping and Survivorship for Genitourinary Cancers
Johns Hopkins University
Recruiting
NCT06427824 2025-10-03
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
University of Chicago
Phase NA Recruiting
NCT04598724 2023-01-03
Addressing Barriers to Palliative Care Use in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT01776138 2021-10-06
PORCH
UNC Lineberger Comprehensive Cancer Center
Completed
NCT01447199 2020-01-07
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
M.D. Anderson Cancer Center
Unknown
NCT03106610 2018-05-24
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01955408 2017-10-06
OABSYNERGO
Meir Medical Center
Completed
NCT00582387 2015-12-18
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center
Completed